by Benzinga Insights | Jan 7, 2026 | General
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.83% on an annualized basis producing an average annual return of 21.62%. Currently, Regeneron Pharmaceuticals has a market capitalization of $82.71 billion. Buying $1000...
by Akanksha Bakshi | Jan 7, 2026 | General
Oklo Inc. (NYSE:OKLO) took a significant step forward in its long-term nuclear ambitions on Wednesday, securing fresh backing from the U.S. government as Washington looks to strengthen domestic supply chains tied to healthcare and advanced energy. The move underscores...
by Benzinga Insights | Jan 7, 2026 | General
Sherwin-Williams (NYSE:SHW) has outperformed the market over the past 15 years by 6.19% on an annualized basis producing an average annual return of 18.07%. Currently, Sherwin-Williams has a market capitalization of $84.89 billion. Buying $1000 In SHW: If an investor...
by Nabaparna Bhattacharya | Jan 7, 2026 | General
Boeing Co. (NYSE:BA) on Wednesday landed a landmark aircraft deal after Alaska Air Group, Inc. (NYSE:ALK) placed its largest order ever. Alaska said it has agreed to purchase 105 Boeing 737-10 jets, the largest variant of the 737 MAX family, along with five Boeing 787...
by Benzinga Insights | Jan 7, 2026 | General
TransDigm Gr (NYSE:TDG) has outperformed the market over the past 5 years by 4.64% on an annualized basis producing an average annual return of 17.47%. Currently, TransDigm Gr has a market capitalization of $77.84 billion. Buying $100 In TDG: If an investor had bought...
Recent Comments